Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey Conn

Showing results (41-50 of 416) with videos related to

Pageof 42
Sort By:
Journal of Cellular Physiology|June 18, 2002
Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populationsOrnella Valenti, P Jeffrey Conn, Michael J Marino
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
NeurotherapeuticsGwenn S Smith, Xiaohua Li, P Jeffrey Conn
Drugs & Aging|April 17, 2003
Glutamate receptors and Parkinson's disease: opportunities for interventionMichael J Marino, Ornella Valenti, P Jeffrey Conn
Neuropharmacology|July 16, 2008
Metabotropic glutamate receptors mGluR4 and mGluR8 regulate transmission in the lateral olfactory tract-piriform cortex synapsePaulianda J Jones, Zixiu Xiang, P Jeffrey Conn
Nature Reviews. Drug Discovery|January 1, 2009
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersP Jeffrey Conn, Arthur Christopoulos, Craig W Lindsley
The European Journal of Neuroscience|August 4, 2007
D1- and D2-like dopamine receptors regulate signaling properties of group I metabotropic glutamate receptors in the rat globus pallidusOlga V Poisik, Yoland Smith, P Jeffrey Conn
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrinJ Phillip Kennedy, P Jeffrey Conn, Craig W Lindsley
Trends in Pharmacological Sciences|February 10, 2009
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersP Jeffrey Conn, Carrie K Jones, Craig W Lindsley
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeuticsMichael J Marino, P Jeffrey Conn, Jeffrey P Conn
Trends in Molecular Medicine|September 30, 2011
Targeting glutamate synapses in schizophreniaJulie R Field, Adam G Walker, P Jeffrey Conn
Pageof 42

Showing results (41-50 of 416) with videos related to

Sort By:
Pageof 42
Journal of Cellular Physiology|June 18, 2002
Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populationsOrnella Valenti, P Jeffrey Conn, Michael J Marino
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
NeurotherapeuticsGwenn S Smith, Xiaohua Li, P Jeffrey Conn
Drugs & Aging|April 17, 2003
Glutamate receptors and Parkinson's disease: opportunities for interventionMichael J Marino, Ornella Valenti, P Jeffrey Conn
Neuropharmacology|July 16, 2008
Metabotropic glutamate receptors mGluR4 and mGluR8 regulate transmission in the lateral olfactory tract-piriform cortex synapsePaulianda J Jones, Zixiu Xiang, P Jeffrey Conn
Nature Reviews. Drug Discovery|January 1, 2009
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersP Jeffrey Conn, Arthur Christopoulos, Craig W Lindsley
The European Journal of Neuroscience|August 4, 2007
D1- and D2-like dopamine receptors regulate signaling properties of group I metabotropic glutamate receptors in the rat globus pallidusOlga V Poisik, Yoland Smith, P Jeffrey Conn
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrinJ Phillip Kennedy, P Jeffrey Conn, Craig W Lindsley
Trends in Pharmacological Sciences|February 10, 2009
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersP Jeffrey Conn, Carrie K Jones, Craig W Lindsley
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeuticsMichael J Marino, P Jeffrey Conn, Jeffrey P Conn
Trends in Molecular Medicine|September 30, 2011
Targeting glutamate synapses in schizophreniaJulie R Field, Adam G Walker, P Jeffrey Conn
Pageof 42